Abstract
: Nabiximols, a cannabinoid-based oromucosal spray, is indicated as add-on therapy for symptomatic relief of spasticity in persons with multiple sclerosis (MS). This review compiles tolerability an...
Funding Information
  • provided by Rob Furlong and Kerry Dechant on behalf of Content Ed Net

This publication has 46 references indexed in Scilit: